Preparing a Pharmaceutical Consulting Inquiry: Questions, Records, and Scope

Have a medication-related project? Discuss a Consulting Project.

A pharmaceutical consulting inquiry works best when it starts with the decision you need to make. Tell PCS what you need examined, what you want to receive, and when you need it. You do not need to solve the clinical question before asking for help.

Perhaps your legal team has a large record set and one stubborn question about a medication change. Perhaps your organization needs an evidence summary before revising a clinical resource. Both are consulting projects. They need different starting materials and different deliverables.

PharmacoLegal Consulting Services™ helps turn a medication-related question into a defined assignment. Discuss a Consulting Project with a short description and your deadline. PCS can clarify the work and provide a proposal.

Start with the decision, not the document pile

“Please review these records” leaves the most important question unanswered: review them for what? A better starting point identifies what the analysis needs to help you understand.

For records work, you might need to trace documented medication changes across a hospital stay. For research, you might need a focused summary of evidence for a particular population. For content, you might need clinical review of a treatment explanation before publication.

These are different assignments even when they concern the same medication. Naming the intended use helps identify the right sources, level of detail, and output. Read the medical record review guide for attorneys for the records-specific pathway.

What to include in a pharmaceutical consulting inquiry

• The question: what do you need examined or explained?
• The intended use: internal discussion, a publication, legal-team analysis, or another defined purpose.
• The material: document types, approximate volume, date range, or the research question if there are no records.
• The deliverable: a chronology, findings report, evidence summary, annotated content, or a discussion of which format would help.
• The timing: your deadline and any earlier milestone.
• Your organization and contact: who will coordinate the assignment and approve the proposal?

A page count helps describe the material; it does not describe all the work. A short, inconsistent record set can raise more questions than a longer, well-organized one. If the volume is uncertain, say so. That is useful information.

A short inquiry that gives PCS something to work with

Original illustrative inquiry; not a client engagement.

Our legal team needs a medication chronology covering one hospital admission and the discharge instructions. We have approximately 450 pages, including orders, administration records, progress notes, and a discharge summary. We want source-linked entries, unresolved differences, and questions for follow-up. Our target deadline is three weeks away. Please advise on the next step for a proposal and confidential document transfer.

This message does not argue a conclusion. It identifies the work. PCS can ask a focused follow-up question instead of starting another round of “What exactly do you need?”

A research inquiry can be equally direct: name the population, medication or intervention, question, and intended audience. See the targeted literature research guide for how the question shapes the search.

Choose the output you will actually use

A useful proposal names the deliverable rather than offering an undefined block of consulting time. Consider what your team needs to do next.

• Medication chronology: follow documented events in sequence with source references.
• Findings report: examine defined questions, supporting material, gaps, and follow-up needs.
• Evidence summary: understand the literature relevant to an agreed question, with sources and search boundaries.
• Annotated content: see comments and recommended revisions against an existing draft.

Several outputs can be combined when the assignment calls for them. A chronology and an evidence summary answer different questions; neither should quietly become an open-ended review of everything.

Describe sensitive records before sending them

Use the initial inquiry for a general project description. Do not paste patient information or upload confidential case material into a general contact message. PCS can first establish the appropriate conflict check, confidentiality arrangements, and document-sharing route for the assignment.

Once the transfer arrangements are confirmed, a simple inventory helps: document types, covered dates, source identifiers, and known omissions. Preserve original files and stable page references so findings can be checked against the material supplied.

For medication analysis, comparing different sources matters. AHRQ’s medication reconciliation guidance describes comparing medication information and clarifying discrepancies.^[1] That guidance concerns care processes; a retrospective consulting review has its own agreed purpose and should not be presented as the same service.

What happens after the inquiry?

PCS reviews the requested work and asks any questions needed to define it. Straightforward assignments may be clarified by email; a project-fit conversation can help when the question needs discussion.

The proposal should specify deliverables, included material, fee, timeline, revision or follow-up arrangements, and payment terms. It should also explain how additional records or new questions will be handled. Work begins after the agreement and required payment arrangements.

If you are considering testimony, identify that separately. A consulting inquiry does not establish a testimony engagement. The requested role and relevant expertise need their own discussion.

Discuss your consulting project with PCS. A clear first message is enough to begin.

Frequently asked questions

References

1. Agency for Healthcare Research and Quality. MATCH Toolkit, Chapter 3: Designing the Medication Reconciliation Process. Used for the distinction between comparing medication information and resolving discrepancies, not as a consulting engagement standard.